Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Langer

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2006
Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studiesH T Mouridsen, S W Langer, J Buter, et al.
Diagnostics (Basel, Switzerland)|November 3, 2020
Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine TumorsJonas Baekdal, Jesper Krogh, Marianne Klose, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 16, 2021
Neuroendocrine neoplasms of the appendix: Characterization of 335 patients referred to the Copenhagen NET Center of ExcellencePernille Holmager, Gro Linno Willemoe, Kirstine Nielsen, et al.
Journal of Neuroendocrinology|August 20, 2021
Increase of Ki-67 index and influence on mortality in patients with neuroendocrine neoplasmsPernille Holmager, Seppo W Langer, Birgitte Federspiel, et al.
Lung Cancer (Amsterdam, Netherlands)|August 25, 2012
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancerBjørn H Grønberg, Tudor Ciuleanu, Øystein Fløtten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung CancerAnders Olin, Claes N Ladefoged, Natasha H Langer, et al.
Annals of Surgical Oncology|December 19, 2015
Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative StudySven-Petter Haugvik, Eva Tiensuu Janson, Pia Österlund, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failedM J Keating, B Cazin, S Coutré, et al.
BMC Cancer|June 6, 2014
Perioperative rehabilitation in operation for lung cancer (PROLUCA) - rationale and designMaja S Sommer, Karen Trier, Jette Vibe-Petersen, et al.
Acta Oncologica (Stockholm, Sweden)|November 7, 2023
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecanMorten Mau-Sørensen, Jonas Gerner-Rasmussen, Olfred Hansen, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2006
Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studiesH T Mouridsen, S W Langer, J Buter, et al.
Diagnostics (Basel, Switzerland)|November 3, 2020
Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine TumorsJonas Baekdal, Jesper Krogh, Marianne Klose, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 16, 2021
Neuroendocrine neoplasms of the appendix: Characterization of 335 patients referred to the Copenhagen NET Center of ExcellencePernille Holmager, Gro Linno Willemoe, Kirstine Nielsen, et al.
Journal of Neuroendocrinology|August 20, 2021
Increase of Ki-67 index and influence on mortality in patients with neuroendocrine neoplasmsPernille Holmager, Seppo W Langer, Birgitte Federspiel, et al.
Lung Cancer (Amsterdam, Netherlands)|August 25, 2012
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancerBjørn H Grønberg, Tudor Ciuleanu, Øystein Fløtten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung CancerAnders Olin, Claes N Ladefoged, Natasha H Langer, et al.
Annals of Surgical Oncology|December 19, 2015
Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative StudySven-Petter Haugvik, Eva Tiensuu Janson, Pia Österlund, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failedM J Keating, B Cazin, S Coutré, et al.
BMC Cancer|June 6, 2014
Perioperative rehabilitation in operation for lung cancer (PROLUCA) - rationale and designMaja S Sommer, Karen Trier, Jette Vibe-Petersen, et al.
Acta Oncologica (Stockholm, Sweden)|November 7, 2023
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecanMorten Mau-Sørensen, Jonas Gerner-Rasmussen, Olfred Hansen, et al.
Pageof 20